Receive Replagal® treatment in the comfort of your own home, according to your own schedule
Bayshore's Replagal (agalsidase alfa) HomePATH Program, sponsored by Shire Human Genetic Therapies, provides home infusion services to patients across Canada with Fabry disease. The HomePATH (Patient Assisted Team Health) Program is a clinical case management program that confidentially and effectively manages all aspects of a Fabry patient's Replagal therapy and associated care.
Replagal is an enzyme replacement therapy that Fabry patients have been prescribed by their physician. The treatment consists of a 40-minute infusion every two weeks. Through our program, patients receive treatment in the privacy of their own homes, at a time that is convenient for them.
Each Fabry patient is assigned a clinical nurse manager who oversees the entire process. When we receive a new referral, our case manager contacts the patient to set up a time for their first infusion, assigns a specially trained nurse, arranges for delivery of infusion supplies and drug to the patient, provides updates to the prescribing physician and follows up regularly with the patient. Our nurses work with all Fabry patients to develop a schedule and care plan tailored to their personal needs.
For more information about our Replagal HomePATH Program, please call 1-877-882-4124.